[1] Compilation group: Guidelines for the diagnosis and treatment of gliomas in the central nervous system in China. Guidelines for the diagnosis and treatment of central nervous system gliomas in China (2015)[J]. Chinese Journal of Medical Science, 2016, 96(7): 485-509.(in Chinese)
《中国中枢神经系统胶质瘤诊断和治疗指南》编写组.中国中枢神经系统胶质瘤诊断与治疗指南(2015)[J].中华医学杂志,2016,96(7):485-509.
[2] Zhang M, Pan JZh, Liu T, et al. Preliminary study of KCTD10 expression in gliomas[J]. Journal of Hunan Normal University (Medical Sciences), 2016, 13(1):6-8.(in Chinese)张敏,潘剑珍,刘彤,等.KCTD10在神经胶质瘤中表达的初步研究[J].湖南师范大学学报(医学版),2016,13(1):6-8.
[3] Zhang P, Feng YN, Wang HZh, et al. Experimental study on the mechanism of Chinese herbal compound antitumor pills in treating glioma[J]. Beijing Journal of Traditional Chinese Medicine, 2017, 36(2): 135-138,193.(in Chinese)
张鹏,冯英楠,王海征,等.中药复方抗瘤丸治疗神经胶质瘤作用机制的实验研究[J].北京中医药,2017,36(2):135-138,193.
[4] Zhang YH, Li H, Liu YCh. Role and mechanism of miRNA in tumor radiotherapy sensitivity[J]. Modern Oncology Medicine, 2016, 24(2): 314-318.(in Chinese)
张玉虹,李皓,刘阳晨.miRNA在肿瘤放疗敏感性中的作用及机制[J].现代肿瘤医学,2016,24(2):314-318.
[5] Shao J, Kong GM, Shi MY, et al. The role of gastric juice microRNA-133a in diagnosis and prognosis of gastric cancer[J]. Acta Anatomica Sinica, 2017,48(5):550-555.(in Chinese)
邵娟,孔桂美,史明仪,等.胃液microRNA-133a在胃癌诊断和预后评估中的作用[J].解剖学报,2017,48(5):550-555.
[6] Lang BJ, Ma JY, Hu YCh, et al. Expression of microRNA-184 in glioma and its prognostic value[J]. Cancer Prevention Research, 2015, 42(5): 48-487.(in Chinese)
郎博娟,马金阳,胡余昌,等.胶质瘤中MicroRNA-184的表达及其预后价值[J].肿瘤防治研究,2015,42(05):483-487.
[7] Li XX, Yu Q, Tian Y, et al. Expression and clinical significance of microRNA-221 in human glioma[J]. Chinese Journal of Modern Medicine, 2015, 25(17):26-29.(in Chinese)
李新星,于奇,田羽,等.人脑胶质瘤中microRNA-221的表达及临床意义[J].中国现代医学杂志,2015,25(17):26-29.
[8] Xu PX, Li Q, Xu QG, et al. Clinical significance and biological effects of miRNA-210 expression in human glioma[J]. Journal of Hainan Medical College, 2017, 23(12): 1675-1678.(in Chinese)
徐鹏翔,李强,许琼冠,等.miRNA-210在人脑胶质瘤中表达的临床意义及其生物学效应的探究[J].海南医学院学报,2017,23(12):1675-1678.
[9] Han YCh, Hu ChH, Yang F, et al. The role of miRNA-145 in brain gliomas[J]. Chinese Journal of Clinical Neurosurgery, 2017, 22(7): 486-488, 523.(in Chinese)
韩铖琛,胡晨浩,杨帆,等.miRNA-145在脑胶质瘤中的作用[J].中国临床神经外科杂志,2017,22(7):486-488,523.
[10]Di G, Wang Z, Wang W, et al.AntagomiR-613 protects neuronal cells from oxygen glucose deprivation/re-oxygenation via increasing SphK2 expression[J].Biochem Biophys Res Commun, 2017,493(1):188-194.
[11]Zhang X, Zhang H.Diminished miR-613 expression as a novel prognostic biomarker for human ovarian cancer[J].Eur Rev Med Pharmacol Sci,2016,20(5):837-841.
[12]Guan S, Wang C, Chen X, et al.MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma[J].Tumour Biol,2016,37(4):4383-4391.
[13]Li D, Li DQ, Liu D, et al.MiR-613 induces cell cycle arrest by targeting CDK4 in non-small cell lung cancer[J].Cell Oncol, 2016, 39 (2):139-147.
[14]Wang W, Zhan H, Wang L, et al.miR-613 inhibits the growth and invasiveness of human hepatocellular carcinoma via targeting DCLK1[J],Biochem Biophys Res Commun,2016, 473 (4):987-992.
[16]Wu J, Yuan P, Mao Q, et al.miR-613 inhibits proliferation and invasion of breast cancer cell via VEGFA[J]. Biochem Biophys Res Commun,2016,478(1):274-278.
|